pyrrolidonecarboxylic acid has been researched along with pidotimod in 99 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 50 (50.51) | 18.2507 |
2000's | 7 (7.07) | 29.6817 |
2010's | 30 (30.30) | 24.3611 |
2020's | 12 (12.12) | 2.80 |
Authors | Studies |
---|---|
Chisari, G; Condorelli, F; di Marco, R; di Mauro, M; Girardello, R; Meroni, PL; Nicoletti, F; Speciale, AM; Uslenghi, C | 1 |
Coppi, G; D'Adamio, L; Migliorati, G; Nicoletti, I; Riccardi, C | 1 |
Coppi, G; D'Adamio, F; Migliorati, G; Nicoletti, I; Pagliacci, C; Riccardi, C | 1 |
Capsoni, F; Girardello, R; Minonzio, F; Ongari, AM; Zanussi, C | 1 |
Forno, B; Girardello, R; Marinelli, L; Pollono, AM; Pugliese, A; Uslenghi, C | 1 |
Coppi, G; Falcone, A; Manzardo, S | 2 |
Auteri, A; Bova, G; Bruni, F; Di Renzo, M; Pasqui, AL; Saletti, M | 1 |
Alfano, S; Biolchini, A; Careddu, P; Zavattini, G | 1 |
Barchielli, M; Coppi, G | 2 |
Annoni, G; Arosio, B; Cullurà, D; Gagliano, N; Santambrogio, D; Uslenghi, C | 1 |
Maillard, F | 1 |
Bocchiola, G; Magni, A; Signorelli, G | 1 |
Anders, U; Bocchiola, G; Crimella, T; Orlandi, R; Stradi, R | 1 |
Coppi, G; Manzardo, S | 1 |
Migliorati, G; Nicoletti, I; Riccardi, C | 1 |
Basilico, N; Cocuzza, C; Malabarba, MG; Mattina, R; Sala, G; Taramelli, D | 1 |
Colangelo, D; Dianzani, C; Guidotto, S; Tonso, E; Viano, I | 1 |
Barbera, N; Bernardini, R; Cantarella, G; Chiarenza, A; Iurato, MP; Lempereur, L; Scapagnini, G; Scapagnini, U | 1 |
Coppi, G; Falcone, A; Ieva, G; Manzardo, S; Pinzetta, A | 1 |
Amico-Roxas, M; Bertè, F; Bussi, R; Coppi, G; Gnemi, P; Harling, RJ; Mailland, F; Manzardo, S; Massey, JE; Spencer-Briggs, DJ | 1 |
Adams, K; Allen, JA; Brooker, PC; Coppi, G; Henderson, L; Jones, E; Mailland, F; Proudlock, RJ | 1 |
Coppi, G; Silingardi, S | 1 |
Coppi, G; Mailland, F; Silingardi, S | 1 |
Biffi, M; Coppi, G; Mailland, F; Silingardi, S; Spotti, D | 1 |
Caravaggi, M; Crema, A; Crema, F; D'Angelo, L; De Ponti, F | 1 |
Benetti, GP; Bombelli, G; Fugazza, L; Illeni, MT; La Vecchia, G; Montalto, F; Stramba Badiale, M; Uslenghi, C | 1 |
Caramia, G; Carnelli, V; Cera, R; Clemente, E; Corsini, A; Mei, V; Solli, R; Venturoli, V | 1 |
Careddu, P; Corsini, A; Mei, V; Venturoli, V | 1 |
Caramia, G; Carnelli, V; Cera, R; Clemente, E; Corsini, A; Mei, V; Ruffini, E; Solli, R; Venturoli, V | 1 |
Cirianni, C; Dolcetti, A; Fugazza, L; Moreo, G; Orlandi, O; Piacenza, G; Pozzi, E; Rampulla, C; Scarpazza, G | 1 |
Bariffi, F; Bertoli, L; Bisetti, A; Cardani, A; Catena, E; Ciappi, G; Grassi, V; Rocco, V; Scarpazza, G; Vaccaro, L | 1 |
Benetti, GP; Bombelli, G; Illeni, MT; Lavecchia, G; Passera, A; Uslenghi, C | 1 |
Careddu, P | 1 |
Calearo, C; Conticello, S; Passali, D | 1 |
Ciaccia, A | 1 |
De Campora, E; De Vita, C; Esposito, S; Galletti, C; Incutti, V; Mallardi, V; Motta, G; Motta, S; Pucci, V; Salonna, F | 1 |
Burgio, GR; De Benedetti, F; Marseglia, GL; Masarone, M; Nespoli, L; Ottolenghi, A; Pagliano, L; Serra, U; Severi, F | 1 |
Broccali, GP; Coppi, G; Dal Bo, L; Silingardi, S | 1 |
Coppi, G; Delfino, D; Maggioni, A; Migliorati, G; Nicoletti, I; Riccardi, C | 1 |
Campa, M; Girardello, R; Lupetti, A; Marelli, P; Senesi, S; Uslenghi, C | 1 |
Caloro, D; Dammacco, F; Di Stefano, R; Ranieri, G; Vacca, A | 1 |
Eftimiadi, C; Oddera, S; Rossi, GA; Sacco, O; Silvestri, M | 1 |
Barcellini, W; Borghi, MO; Carbonelli, V; Del Papa, N; Fain, C; Gambini, D; La Rosa, L; Meroni, PL; Minonzio, F; Piona, A | 1 |
Auteri, A; Bova, G; Bruni, F; Di Renzo, M; Gotti, G; Pasqui, AL; Saletti, M | 1 |
Annoni, G; Arosio, B; Gagliano, N; Santambrogio, D | 1 |
Auteri, A; Bova, G; Bruni, F; Chiarion, C; Di Renzo, M; Ferrì, P; Girardello, R; Pasqui, AL; Saletti, M | 1 |
Guerra, B; Perino, A; Polatti, F; Scala, M | 1 |
Di Mauro, M; Grillo, C; La Mantia, I; Mattina, T; Meroni, PL; Nicoletti, F; Xiang, M; Zaccone, P | 1 |
Aivazis, V; Hatzimichail, A; Iuga-Donca, G; Papachristou, A; Valeri, R | 1 |
Bossios, A; Gourgiotis, D; Papadopoulos, NG; Saxoni-Papageorgiou, P; Zamanis, P | 1 |
Larcombe, J | 1 |
Choung, SY; Du, XF; Jiang, CZ; Won, EK; Wu, CF | 1 |
Choung, SY; Du Xiao, F; Jiang, CZ; Won, EK; Wu, CF | 1 |
Li, F; Liu, W; Lu, S; Qin, F; Xiong, Z; Zhang, Y | 1 |
Avolio, M; Becker, PD; Caruso, A; Fiorentini, S; Giagulli, C; Guzman, CA; Noerder, M | 1 |
Li, F; Qin, F; Qin, T; Xiong, Z; Yang, S; Zhang, Y | 1 |
Hu, Z; Qi, X; Wang, L; Zhang, J; Zhu, J | 1 |
Qi, X; Wang, L; Zhu, J | 1 |
Jiang, B; Lou, HG; Ruan, ZR | 1 |
Hu, X; Hua, H; Li, W; Shan, F; Wan, N; Wang, B; Wang, L; Zhang, W | 1 |
Meng, Y; Plotnikoff, NP; Shan, F; Wang, E; Wang, Q; Zhang, Z | 1 |
Huang, JH; Huang, XH; Li, JC; Li, LJ; Shen, CL; Wang, K; Xie, XF; Zheng, QS | 1 |
Carta, S; Rossi, GA; Silvestri, M | 1 |
Cai, YH; Chen, H; Chen, ZW; Du, J; Fu, Y; Huo, XX; Lu, FL; Lun, ZR; Luo, QL; Shen, JL; Song, XR; Wang, H; Wang, L; Wang, Y; Xu, XC; Xu, YH; Zhang, AM | 1 |
Huang, B; Huang, S; Kasper, LH; Li, YQ; Lu, F; Lun, ZR; Shen, J; Wang, Y; Zhao, Y; Zheng, H | 1 |
Mameli, C; Zuccotti, GV | 1 |
Chen, Q; Hu, T; Jin, X; Zeng, X; Zhao, X | 1 |
Du, W; Fu, A; Fu, X; Hu, S; Ji, J; Li, W | 1 |
Chen, H; Huo, XX; Kong, LT; Li, M; Shen, JL; Wang, WW; Zhang, Q | 1 |
Artusio, L; Caimmi, S; De Amici, M; Licari, A; Marseglia, A; Marseglia, GL; Nigrisoli, S | 1 |
Bedogni, G; Mameli, C; Pasinato, A; Picca, M; Pisanelli, S; Zuccotti, GV | 1 |
Buongiorno, A; Pierossi, N | 1 |
Biasin, M; Clerici, M; Esposito, S; Garziano, M; Marchisio, P; Principi, N; Rainone, V; Rossi, M; Senatore, L; Trabattoni, D | 1 |
Chen, Y; Dou, X; Shen, W; Su, X; Wang, Y | 1 |
Chen, H; Kang, D; Liang, Y; Rao, T; Shao, Y; Shen, B; Wang, G; Wang, Q; Xiao, J | 1 |
Hayward, A; Lakhanpaul, M; Littlejohns, P; Manikam, L; Reed, K; Schilder, A; Venekamp, RP | 1 |
Chen, J; He, Y; Huang, J; Li, M; Lv, Y; Wang, J; Wang, K; Xu, L; Yang, J; Zheng, Q | 1 |
Blasi, F; Centanni, S; Clerici, M; Garziano, M; Mantero, M; Trabattoni, D | 1 |
Cui, L; Dai, C; Hao, Z; Qiu, M; Qu, S; Wang, C; Zhang, R | 1 |
Fu, AK; Fu, LQ; Hu, SL; Li, WF; Li, YL; Wang, YY; Wu, YP | 1 |
Cui, L; Hao, Z; Qiu, M; Wang, C; Zhang, R; Zhao, L; Zhu, J | 1 |
Cai, Y; Jia, YT; Niu, H; Wang, R | 1 |
Baraldi, E; Bozzetto, S; Giordano, G; Montella, S; Pirillo, P; Poeta, M; Santamaria, F; Stocchero, M | 1 |
Dong, X; Liu, C; Liu, X; Zhao, N; Zhu, C | 1 |
Bugatti, A; Caccuri, F; Caruso, A; Corbellini, S; Giagulli, C; Marsico, S; Mazzuca, P; Roversi, S; Zani, A | 1 |
Carsetti, R; Di Camillo, C; Marcellini, V; Mirante, N; Valentini, D; Villani, A | 1 |
Canonica, GW; Feleszko, W; Kalyuzhin, O; Krenke, R; Rossi, GA; Van Gerven, L | 1 |
Cui, J; Gao, J; Guo, W; Li, A; Wu, T; Zhou, H | 1 |
Brindisi, G; Conte, MP; De Castro, G; Duse, M; Gori, A; Leonardi, L; Marazzato, M; Schiavi, L; Zicari, AM | 1 |
Barone, P; Filosco, F; Finocchiaro, GG; Giugno, A; Leonardi, S; Manti, S; Papale, M; Parisi, GF | 1 |
Leonardi, S; Manti, S; Papale, M; Parisi, GF | 1 |
Al Basir, F; Chatterjee, AN | 1 |
Huang, J; Li, L; Liu, H; Wen, X; Zhang, W; Zheng, Q | 1 |
Jafrey, SZ; Karadkhele, A; Mahashur, A; Muchhala, S; Rathod, R; Suvarna, V; Vora, A; Waghray, P | 1 |
Antonini, S; Becherucci, P; Biasci, P; Bortone, B; Bottero, S; Caldarelli, V; Cardinale, F; Chiappini, E; Ciarcià, M; Ciofi, D; Cutrera, R; D'Elios, S; de Martino, M; Del Giudice, MM; Di Mauro, G; Doria, M; Galli, L; Gattinara, GC; Indinnimeo, L; Lo Vecchio, A; Macrì, F; Marchisio, P; Marseglia, GL; Mattina, R; Miniello, VL; Morbin, G; Motisi, MA; Novelli, A; Palamara, AT; Panatta, ML; Pasinato, A; Peroni, D; Perruccio, K; Piacentini, G; Pifferi, M; Pignataro, L; Santamaria, F; Sitzia, E; Tersigni, C; Torretta, S; Trambusti, I; Trippella, G; Valentini, D; Valentini, S; Varricchio, A; Verga, MC; Vicini, C; Villani, A; Zecca, M | 1 |
Ding, L; Feng, CG; Luo, K; Oehlers, SH | 1 |
Deglurkar, R; Mathew, JL; Singh, M | 1 |
7 review(s) available for pyrrolidonecarboxylic acid and pidotimod
Article | Year |
---|---|
Urinary tract infection in children.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Female; Humans; Infant; Male; Pyelonephritis; Pyrrolidonecarboxylic Acid; Secondary Prevention; Thiazoles; Thiazolidines; Urinary Tract Infections; Vesico-Ureteral Reflux | 2005 |
Limited Evidence on the Management of Respiratory Tract Infections in Down's Syndrome: A Systematic Review.
Topics: Anti-Infective Agents; Bias; Clinical Trials as Topic; Down Syndrome; Humans; Palivizumab; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; Thiazolidines; Zinc | 2016 |
Pidotimod, an immunostimulant in pediatric recurrent respiratory tract infections: A meta-analysis of randomized controlled trials.
Topics: Adjuvants, Immunologic; Child; Child, Preschool; Humans; Immunity, Cellular; Immunity, Humoral; Immunoglobulins; Infant; Infant, Newborn; Pyrrolidonecarboxylic Acid; Randomized Controlled Trials as Topic; Recurrence; Respiratory Tract Infections; T-Lymphocyte Subsets; T-Lymphocytes; Thiazolidines | 2019 |
Pidotimod: a review of its pharmacological features and clinical effectiveness in respiratory tract infections.
Topics: Acute Disease; Animals; Humans; Immunologic Factors; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; Risk Factors; Thiazolidines; Treatment Outcome | 2019 |
Immunoactive preparations and regulatory responses in the respiratory tract: potential for clinical application in chronic inflammatory airway diseases.
Topics: Asthma; Cell Extracts; Chronic Disease; Humans; Immunization; Immunologic Factors; Immunomodulation; Inflammation; Probiotics; Pulmonary Disease, Chronic Obstructive; Pyrrolidonecarboxylic Acid; Respiratory System; Respiratory Tract Diseases; Rhinitis; Sinusitis; Thiazolidines | 2020 |
Pidotimod in allergic diseases.
Topics: Adaptive Immunity; Adjuvants, Immunologic; Adolescent; Asthma; Child; Child, Preschool; Chronic Urticaria; Dermatitis, Atopic; Desensitization, Immunologic; Food Hypersensitivity; Humans; Hypersensitivity; Immunity, Innate; Immunologic Factors; Pyrrolidonecarboxylic Acid; Rhinitis, Allergic; Thiazolidines | 2020 |
Whether Immunostimulants Are Effective in Susceptible Children Suffering From Recurrent Respiratory Tract Infections: A Modeling Analysis Based on Literature Aggregate Data.
Topics: Adjuvants, Immunologic; Cell Extracts; Child; Female; Humans; Male; Models, Biological; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; Thiazolidines | 2022 |
32 trial(s) available for pyrrolidonecarboxylic acid and pidotimod
Article | Year |
---|---|
Pidotimod in the prophylaxis of recurrent acute tonsillitis in childhood.
Topics: Acute Disease; Adolescent; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Pyrrolidonecarboxylic Acid; Recurrence; Thiazoles; Thiazolidines; Tonsillitis | 1992 |
Pharmacokinetics and oral bioavailability of pidotimod in humans.
Topics: Administration, Oral; Adolescent; Adult; Biological Availability; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Immunologic Factors; Injections, Intramuscular; Male; Middle Aged; Protein Binding; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1994 |
Pharmacokinetics of pidotimod in elderly volunteers and in renal failure patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Female; Half-Life; Humans; Immunologic Factors; Injections, Intravenous; Intestinal Absorption; Male; Middle Aged; Pyrrolidonecarboxylic Acid; Renal Insufficiency; Thiazoles; Thiazolidines; Urea | 1994 |
Effect of food on the bioavailability of pidotimod in healthy volunteers.
Topics: Adult; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Food-Drug Interactions; Humans; Immunologic Factors; Male; Pyrrolidonecarboxylic Acid; Spectrophotometry, Ultraviolet; Therapeutic Equivalency; Thiazoles; Thiazolidines | 1994 |
Ex vivo evaluation of pidotimod activity on cell-mediated immunity.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; CD3 Complex; Double-Blind Method; Female; Humans; Immunity, Cellular; Lymphocyte Count; Male; Middle Aged; Neoplasms; Phytohemagglutinins; Pyrrolidonecarboxylic Acid; Stimulation, Chemical; T-Lymphocytes; Thiazoles; Thiazolidines | 1994 |
Efficacy and safety of pidotimod in the treatment of recurrent respiratory infections in children.
Topics: Adjuvants, Immunologic; Anti-Bacterial Agents; Chemotaxis, Leukocyte; Child; Double-Blind Method; Female; Humans; Infant; Male; Phagocytosis; Pyrrolidonecarboxylic Acid; Recurrence; Respiratory Tract Infections; Thiazoles; Thiazolidines | 1994 |
Pidotimod in the treatment of recurrent respiratory infections in paediatric patients.
Topics: Bronchitis; Child; Child, Preschool; Double-Blind Method; Female; Humans; Immunologic Factors; Laryngitis; Lymphocyte Count; Male; Otitis; Pharyngitis; Pyrrolidonecarboxylic Acid; Recurrence; Respiratory Tract Infections; Rhinitis; Thiazoles; Thiazolidines; Tracheitis | 1994 |
Therapeutic efficacy and safety of pidotimod in the treatment of urinary tract infections in children.
Topics: Anti-Infective Agents, Urinary; Chemotaxis, Leukocyte; Child; Child, Preschool; Double-Blind Method; Female; Humans; Immunologic Factors; Male; Phagocytosis; Pyrrolidonecarboxylic Acid; Recurrence; Thiazoles; Thiazolidines; Urinary Tract Infections | 1994 |
Pidotimod in the treatment of patients affected by bacterial exacerbations of chronic bronchitis.
Topics: Adult; Aged; Bronchitis; Chronic Disease; Double-Blind Method; Female; Humans; Immunologic Factors; Male; Middle Aged; Pyrrolidonecarboxylic Acid; Recurrence; Respiratory Tract Infections; Skin Tests; Sputum; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Thiazoles; Thiazolidines | 1994 |
Evaluation of the efficacy of pidotimod in the exacerbations in patients affected with chronic bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Bronchitis; Chronic Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Immunologic Factors; Male; Middle Aged; Pyrrolidonecarboxylic Acid; Respiratory Function Tests; Thiazoles; Thiazolidines | 1994 |
Ex vivo evaluation of pidotimod activity in patients with chronic obstructive pulmonary disease.
Topics: Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Double-Blind Method; Female; Follow-Up Studies; Granulocytes; Humans; Lung Diseases, Obstructive; Lymphocyte Activation; Lymphocytes; Macrophages; Male; Middle Aged; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1994 |
Role of immunoactivation with pidotimod in recurrent respiratory infections in childhood.
Topics: Adjuvants, Immunologic; Adolescent; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Pyrrolidonecarboxylic Acid; Recurrence; Respiratory Tract Infections; Risk Factors; Thiazoles; Thiazolidines; Tonsillitis | 1994 |
Pidotimod in the management of recurrent pharyngotonsillar infections in childhood.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Child; Double-Blind Method; Female; Humans; Male; Pharyngitis; Pyrrolidonecarboxylic Acid; Recurrence; Thiazoles; Thiazolidines; Tonsillitis | 1994 |
Pidotimod activity against chronic bronchitis exacerbations.
Topics: Adjuvants, Immunologic; Aged; Bronchitis; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Dropouts; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1994 |
Immunoactivity of pidotimod against episodes of recurrent tonsillitis in childhood.
Topics: Adjuvants, Immunologic; Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents; Child; Child, Preschool; Double-Blind Method; Female; Humans; Male; Pyrrolidonecarboxylic Acid; Recurrence; Thiazoles; Thiazolidines; Tonsillitis | 1994 |
Immunoactivation by pidotimod in children with recurrent respiratory infections.
Topics: Adjuvants, Immunologic; Adolescent; Child; Child, Preschool; Double-Blind Method; Female; Humans; Interleukin-2; Leukocytes; Male; Phytohemagglutinins; Pyrrolidonecarboxylic Acid; Receptors, Interleukin-2; Recurrence; Respiratory Tract Infections; Thiazoles; Thiazolidines | 1994 |
[Pidotimod, a new biological response modifier, is able to partially prevent immune response changes related to surgical stress].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Anesthesia, General; Antibody Formation; Complement C3; Complement C4; Double-Blind Method; Female; Humans; Immune System; Immunologic Deficiency Syndromes; Interleukin-2; Lymphocyte Activation; Lymphocyte Subsets; Male; Middle Aged; Neutrophils; Phagocytosis; Pyrrolidonecarboxylic Acid; Respiratory Burst; Stress, Physiological; Surgical Procedures, Operative; Thiazoles; Thiazolidines | 1993 |
Pidotimod in the management of vulvar papillomatosis: double-blind clinical trial versus placebo.
Topics: Administration, Oral; Adolescent; Adult; Biopsy; Colposcopy; Condylomata Acuminata; Double-Blind Method; Female; Humans; Immunologic Factors; Middle Aged; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Treatment Outcome; Vulvar Diseases | 1998 |
Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome.
Topics: Adolescent; Child; Child, Preschool; Down Syndrome; Female; Humans; Immunologic Factors; Incidence; Male; Pyrrolidonecarboxylic Acid; Recurrence; Respiratory Tract Infections; Severity of Illness Index; Thiazoles; Thiazolidines | 1999 |
Clinical evaluation and changes of the respiratory epithelium function after administration of Pidotimod in Greek children with recurrent respiratory tract infections.
Topics: Adjuvants, Immunologic; Child; Child, Preschool; Female; Greece; Humans; Male; Mucociliary Clearance; Prospective Studies; Pyrrolidonecarboxylic Acid; Respiratory Mucosa; Respiratory Tract Infections; Thiazoles; Thiazolidines; Treatment Outcome | 2002 |
Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of adefovir in human plasma and its application to a pharmacokinetic study.
Topics: Adenine; Administration, Oral; Antiviral Agents; Chromatography, Liquid; Drug Stability; Humans; Limit of Detection; Male; Organophosphonates; Pyrrolidonecarboxylic Acid; Quality Control; Reference Standards; Reproducibility of Results; Tandem Mass Spectrometry; Thiazolidines; Time Factors | 2010 |
Quantitative determination of pidotimod in human plasma by liquid chromatography tandem mass spectrometry: application to a bioequivalence study.
Topics: Adjuvants, Immunologic; Area Under Curve; Asian People; Chromatography, High Pressure Liquid; Cross-Over Studies; Double-Blind Method; Half-Life; Humans; Indicators and Reagents; Pyrrolidonecarboxylic Acid; Quality Control; Reference Standards; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Therapeutic Equivalency; Thiazolidines | 2012 |
Bioequivalence evaluation of two formulations of pidotimod using a limited sampling strategy.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Chemistry, Pharmaceutical; Cross-Over Studies; Healthy Volunteers; Humans; Male; Models, Theoretical; Pyrrolidonecarboxylic Acid; Therapeutic Equivalency; Thiazolidines; Young Adult | 2013 |
Pidotimod may prevent recurrent respiratory infections in children.
Topics: Adjuvants, Immunologic; Child; Child, Preschool; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; Thiazolidines; Treatment Outcome | 2014 |
Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
Topics: Acute Disease; Adjuvants, Immunologic; Child Day Care Centers; Double-Blind Method; Female; Humans; Immunization; Incidence; Infant; Male; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; Risk Reduction Behavior; Thiazolidines; Treatment Outcome | 2015 |
Immunomodulatory activity of pidotimod administered with standard antibiotic therapy in children hospitalized for community-acquired pneumonia.
Topics: Adjuvants, Immunologic; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Dendritic Cells; Female; Hospitalization; Humans; Immunity, Innate; Inflammation; Interleukin-12; Male; Peptides; Pneumonia; Polysaccharides, Bacterial; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; RNA, Messenger; Thiazolidines; Tumor Necrosis Factor-alpha | 2015 |
Advantage of population pharmacokinetic method for evaluating the bioequivalence and accuracy of parameter estimation of pidotimod.
Topics: Adolescent; Adult; Area Under Curve; Asian People; Cross-Over Studies; Humans; Immunologic Factors; Male; Models, Biological; Nonlinear Dynamics; Pyrrolidonecarboxylic Acid; Therapeutic Equivalency; Thiazolidines; Young Adult | 2016 |
Immunomodulatory effects of pidotimod in adults with community-acquired pneumonia undergoing standard antibiotic therapy.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; Female; Hospitalization; Humans; Immunity, Innate; Immunologic Factors; Levofloxacin; Male; Middle Aged; Pneumonia; Prospective Studies; Pyrrolidonecarboxylic Acid; Thiazolidines; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
Effects of pidotimod and bifidobacteria mixture on clinical symptoms and urinary metabolomic profile of children with recurrent respiratory infections: a randomized placebo-controlled trial.
Topics: Adjuvants, Immunologic; Bifidobacterium; Child; Child, Preschool; Female; Humans; Placebos; Pregnancy; Probiotics; Prospective Studies; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; Thiazolidines; Trial of Labor | 2019 |
Efficacy of Pidotimod use in treating allergic rhinitis in a pediatric population.
Topics: Adenoids; Age Factors; Child; Female; Humans; Hypertrophy; Immunologic Factors; Italy; Male; Nasal Obstruction; Pyrrolidonecarboxylic Acid; Rhinitis, Allergic; Thiazolidines; Treatment Outcome | 2020 |
Proposal for a new therapeutic high dosage of Pidotimod in children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome: a randomized controlled study.
Topics: Betamethasone; Child; Child, Preschool; Cross-Over Studies; Familial Mediterranean Fever; Female; Glucocorticoids; Humans; Immunologic Factors; Lymphadenitis; Male; Pharyngitis; Prospective Studies; Pyrrolidonecarboxylic Acid; Stomatitis, Aphthous; Syndrome; Thiazolidines; Treatment Outcome | 2020 |
Efficacy and Safety of Pidotimod in Persistent Asthma: A Randomized Triple-Blinded Placebo-Controlled Trial.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Asthma; Budesonide; Child; Double-Blind Method; Humans; Metered Dose Inhalers; Pyrrolidonecarboxylic Acid; Thiazolidines | 2022 |
60 other study(ies) available for pyrrolidonecarboxylic acid and pidotimod
Article | Year |
---|---|
Increased rate of survival in Streptococcus pneumoniae-infected rats treated with the new immunomodulator Pidotimod.
Topics: Adjuvants, Immunologic; Animals; Male; Pneumonia, Pneumococcal; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Thiazoles; Thiazolidines | 1992 |
Pidotimod stimulates natural killer cell activity and inhibits thymocyte cell death.
Topics: Adjuvants, Immunologic; Animals; Apoptosis; Calcium; Cellular Senescence; Cytotoxicity, Immunologic; Killer Cells, Natural; Mice; Mice, Inbred C3H; Pyrrolidonecarboxylic Acid; Spleen; T-Lymphocytes; Thiazoles; Thiazolidines | 1992 |
Immunopharmacology of Pidotimod: effect on natural killer cell activity and thymocyte cell death.
Topics: Animals; Apoptosis; Cell Death; Dexamethasone; Killer Cells, Natural; Mice; Mice, Inbred C3H; Pyrrolidonecarboxylic Acid; T-Lymphocytes; Thiazoles; Thiazolidines | 1992 |
Evaluation of the kinetics of the immunomodulating activity of Pidotimod on human neutrophils.
Topics: Adjuvants, Immunologic; Adult; Humans; Neutrophils; Phagocytosis; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1992 |
Ex vivo evaluation of Pidotimod effect on immune response.
Topics: Adjuvants, Immunologic; Adult; Chemotaxis, Leukocyte; Humans; Immunity, Cellular; Lymphocyte Activation; Male; Phytohemagglutinins; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1992 |
Activity of the new immunostimulant PGT/1A against experimental bacterial infections.
Topics: Adjuvants, Immunologic; Animals; Bacterial Infections; Male; Mice; Mice, Inbred ICR; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1992 |
Effect of Pidotimod, a new immunostimulating agent, on some aspects of immune response. In vitro study.
Topics: Adjuvants, Immunologic; Complement System Proteins; Humans; Immunity, Cellular; Lymphocyte Activation; Lymphocytes; Neutrophils; Phagocytosis; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1992 |
Simple high-performance liquid chromatographic method for the determination of PGT/1A, a new immunostimulating drug, in biological fluids.
Topics: Acetonitriles; Adjuvants, Immunologic; Adult; Chromatography, High Pressure Liquid; Humans; Injections, Intravenous; Male; Phosphates; Potassium; Potassium Compounds; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1991 |
Activity of PGT/1A, a new immunostimulating drug, on macrophages and lymphocytes in immunodepressed mice.
Topics: Adjuvants, Immunologic; Animals; Bacterial Infections; Immunosuppression Therapy; Lymphocytes; Macrophages; Mice; Pyrrolidinones; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1990 |
Gene expression for interleukin-2 and tumor necrosis factor-alpha in the spleen of old rats under physiological condition and during septic shock. Possible pharmacological modulation.
Topics: Aging; Animals; Blotting, Northern; Gene Expression Regulation; Immunologic Factors; Interleukin-2; Male; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; RNA; Shock, Septic; Spleen; Thiazoles; Thiazolidines; Tumor Necrosis Factor-alpha | 1994 |
Pidotimod. A new biological response modifier. Introduction.
Topics: Adjuvants, Immunologic; Animals; Bacterial Infections; Humans; Immunologic Factors; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1994 |
Synthesis and preliminary pharmacological evaluation of pidotimod, its enantiomer, diastereomers and carboxamido derivatives.
Topics: Adjuvants, Immunologic; Animals; Bacterial Infections; Immunologic Factors; Macrophages; Male; Mice; Mice, Inbred Strains; Prednisolone; Pyrrolidonecarboxylic Acid; Stereoisomerism; Structure-Activity Relationship; Superoxides; Thiazoles; Thiazolidines | 1994 |
Analytical and chemical profile of pidotimod.
Topics: Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Immunologic Factors; Isomerism; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Weight; Pyrrolidonecarboxylic Acid; Solubility; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Thermogravimetry; Thiazoles; Thiazolidines | 1994 |
Experimental immunological screening tests on pidotimod.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; B-Lymphocytes; Chemotaxis, Leukocyte; Dinitrochlorobenzene; Graft vs Host Reaction; Hypersensitivity, Delayed; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mononuclear Phagocyte System; Organ Size; Pyrrolidonecarboxylic Acid; Sheep; Spleen; T-Lymphocytes; Thiazoles; Thiazolidines; Thymus Gland | 1994 |
Protective effects of pidotimod against experimental bacterial infections in mice.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Cyclophosphamide; Enterobacteriaceae Infections; Immunosuppression Therapy; Lactams; Male; Mice; Mice, Inbred Strains; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1994 |
Immunomodulating activity of pidotimod.
Topics: Adjuvants, Immunologic; Animals; Apoptosis; Calcimycin; Cell Division; DNA; Female; Flow Cytometry; Killer Cells, Natural; Male; Mice; Mice, Inbred C3H; Mitogens; Protein-Tyrosine Kinases; Pyrrolidonecarboxylic Acid; Spleen; T-Lymphocytes; Thiazoles; Thiazolidines; Tissue Plasminogen Activator; Tumor Cells, Cultured | 1994 |
Effects of pidotimod on macrophage functions in methylprednisolone-treated mice.
Topics: Adjuvants, Immunologic; Animals; Aspergillus fumigatus; Cell Adhesion; Cell Division; Cytokines; Female; Interferon-gamma; Lipopolysaccharides; Macrophages; Methylprednisolone; Mice; Mice, Inbred Strains; Nitric Oxide; Pyrrolidonecarboxylic Acid; Spores, Fungal; Thiazoles; Thiazolidines; Tumor Necrosis Factor-alpha | 1994 |
In vivo antiviral effects of pidotimod.
Topics: Adjuvants, Immunologic; Animals; Antiviral Agents; Cardiovirus Infections; Herpes Simplex; Influenza A virus; Male; Mengovirus; Mice; Orthomyxoviridae Infections; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines; Virus Diseases | 1994 |
Effects of pidotimod on the immune and the neuroendocrine system in the aging rat.
Topics: Adjuvants, Immunologic; Adrenocorticotropic Hormone; Aging; Animals; Cytokines; Immune System; Immunologic Factors; Interleukin-1; Lymphocytes; Male; Mitogens; Neurosecretory Systems; Pituitary-Adrenal System; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Spleen; Thiazoles; Thiazolidines | 1994 |
General pharmacology of pidotimod and testing for drug interactions.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Autonomic Nervous System; Behavior, Animal; Central Nervous System; Diuresis; Dogs; Drug Interactions; Guinea Pigs; Hemodynamics; Immunologic Factors; In Vitro Techniques; Male; Mice; Muscle, Smooth; Pyrrolidonecarboxylic Acid; Rabbits; Rats; Respiration; Thiazoles; Thiazolidines | 1994 |
Toxicological evaluation of pidotimod.
Topics: Animals; Dogs; Female; Fertility; Lethal Dose 50; Male; Mice; Mice, Inbred Strains; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Teratogens; Thiazoles; Thiazolidines | 1994 |
Genotoxicity testing of pidotimod in vitro and in vivo.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Cells, Cultured; CHO Cells; Chromosome Aberrations; Cricetinae; DNA Repair; Erythrocytes; HeLa Cells; Humans; In Vitro Techniques; Mice; Micronucleus Tests; Mutagenicity Tests; Mutagens; Pyrrolidonecarboxylic Acid; Rats; Salmonella typhimurium; Thiazoles; Thiazolidines | 1994 |
Pharmacokinetics of pidotimod in rats and dogs.
Topics: Administration, Oral; Animals; Biological Availability; Chromatography, High Pressure Liquid; Dogs; Half-Life; Immunologic Factors; Injections, Intramuscular; Injections, Intravenous; Male; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; Thiazoles; Thiazolidines; Tissue Distribution | 1994 |
A new HPLC method for pidotimod plasma levels determination.
Topics: Adult; Chromatography, High Pressure Liquid; Humans; Immunologic Factors; Male; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1993 |
[Pidotimod causes apoptotic cell death and inhibits the proliferative activity of YAC-1 tumor cells in vitro].
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Apoptosis; Biological Transport; Calcium; Cell Division; DNA, Neoplasm; Drug Screening Assays, Antitumor; G2 Phase; Lymphoma, T-Cell; Mice; Mice, Inbred A; Mitosis; Neoplasm Proteins; Neoplastic Stem Cells; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Pyrrolidonecarboxylic Acid; T-Lymphocytes; Thiazoles; Thiazolidines; Tumor Cells, Cultured | 1993 |
[Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice].
Topics: Adjuvants, Immunologic; Animals; Bacterial Infections; Coxsackievirus Infections; Enterovirus B, Human; Female; Immunity, Innate; Influenza A virus; Mice; Mice, Inbred BALB C; Orthomyxoviridae Infections; Pyrrolidonecarboxylic Acid; Streptococcal Infections; Streptococcus agalactiae; Thiazoles; Thiazolidines; Virus Diseases | 1993 |
[Stimulation of B-cell immunity in the nude mice by pidotimod: immunohistochemical stucy of various lymphoid organs].
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; B-Lymphocytes; Cell Differentiation; Immunoenzyme Techniques; Immunoglobulins; Immunologic Deficiency Syndromes; Intestinal Mucosa; Lung; Lymph Nodes; Lymphocyte Activation; Lymphoid Tissue; Mice; Mice, Nude; Pyrrolidonecarboxylic Acid; Spleen; Thiazoles; Thiazolidines | 1993 |
[Effect of pidotimod on phagocytosis and intracellular killing of Staphylococcus aureus by human circulating polymorphonuclear neutrophils and alveolar macrophages].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Coloring Agents; Cytotoxicity, Immunologic; Female; Fluorescent Dyes; Humans; Hydrogen Peroxide; Indoles; Macrophage Activation; Macrophages, Alveolar; Male; Microscopy, Fluorescence; Neutrophils; Phagocytosis; Pyrrolidonecarboxylic Acid; Respiratory Burst; Staphylococcus aureus; Thiazoles; Thiazolidines | 1993 |
[Effect of pidotimod on the function of the human immune system: in vitro and ex vivo study].
Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Aged; Aged, 80 and over; Aging; Antibody Formation; Chemotaxis, Leukocyte; Humans; Immune System; Interferon-gamma; Interleukin-1; Interleukin-2; Interleukin-6; Lymphocyte Activation; Lymphocyte Subsets; Mitogens; Muromonab-CD3; Neutrophils; Phagocytosis; Phytohemagglutinins; Pyrrolidonecarboxylic Acid; Tetradecanoylphorbol Acetate; Thiazoles; Thiazolidines | 1993 |
[Levels of interleukin-2 )IL-2 and tumor necrosis factor alpha (TNF-alpha) mRNA in aged rat spleen under physiological conditions and in septic shock: possible role of pidotimod in gene expression modulation].
Topics: Adjuvants, Immunologic; Aging; Animals; Escherichia coli Infections; Gene Expression Regulation; Interleukin-2; Male; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; RNA, Messenger; Shock, Septic; Spleen; Stimulation, Chemical; Thiazoles; Thiazolidines; Tumor Necrosis Factor-alpha | 1993 |
The in vitro effect of Pidotimod on some immune functions in cancer patients.
Topics: Adjuvants, Immunologic; Female; Humans; Immunity, Cellular; Immunologic Factors; Interleukin-2; Leukocytes, Mononuclear; Lymphocyte Activation; Male; Neoplasms; Pyrrolidonecarboxylic Acid; Thiazoles; Thiazolidines | 1997 |
Immune modulator pidotimod decreases the in vitro expression of CD30 in peripheral blood mononuclear cells of atopic asthmatic and normal children.
Topics: Asthma; Child; Child, Preschool; Cytokines; Down-Regulation; Female; Humans; Hypersensitivity; Immunologic Factors; Ki-1 Antigen; Leukocytes, Mononuclear; Male; Pyrrolidonecarboxylic Acid; T-Lymphocytes, Helper-Inducer; Thiazoles; Thiazolidines | 2004 |
Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression.
Topics: Adjuvants, Immunologic; Animals; Body Weight; C-Reactive Protein; Cell Proliferation; Cell Survival; Cyclophosphamide; Drug Synergism; Immunosuppressive Agents; Killer Cells, Natural; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Nitric Oxide; Organ Size; Panax; Polysaccharides; Pyrrolidonecarboxylic Acid; Spleen; Tetrazolium Salts; Thiazoles; Thiazolidines | 2008 |
Synergistic immunostimulatory effect of pidotimod and red ginseng acidic polysaccharide on humoral immunity of immunosuppressed mice.
Topics: Adjuvants, Immunologic; Alanine Transaminase; Animals; Antibody Formation; Antineoplastic Agents, Alkylating; Cell Count; Cyclophosphamide; Drug Synergism; Erythrocytes; Female; Immunoglobulin E; Immunoglobulin G; Immunosuppression Therapy; Kidney Function Tests; Leukocytes; Liver Function Tests; Lymph Nodes; Mice; Mice, Inbred BALB C; Panax; Plant Extracts; Polysaccharides; Pyrrolidonecarboxylic Acid; Spleen; Thiazolidines; Thymus Gland | 2008 |
High-performance liquid chromatography-tandem mass spectrometry for the determination of pidotimod in human plasma and its application to a pharmacokinetic study.
Topics: Chromatography, High Pressure Liquid; Humans; Immunologic Factors; Male; Pyrrolidonecarboxylic Acid; Tandem Mass Spectrometry; Thiazolidines | 2009 |
Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.
Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Antigens, CD; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Cytotoxicity, Immunologic; Dendritic Cells; Female; HLA-DR Antigens; Humans; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Nasal Mucosa; Ovalbumin; Peptide Fragments; Pyrrolidonecarboxylic Acid; Th1 Cells; Thiazolidines; Tumor Necrosis Factor-alpha | 2009 |
Self-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeability.
Topics: Administration, Oral; Animals; Drug Delivery Systems; Drug Stability; Drug Storage; Emulsions; Male; Permeability; Pyrrolidonecarboxylic Acid; Rats; Rats, Sprague-Dawley; Solubility; Surface-Active Agents; Thiazolidines | 2011 |
Water-in-oil-in-water double emulsions: an excellent delivery system for improving the oral bioavailability of pidotimod in rats.
Topics: Administration, Oral; Animals; Biological Availability; Drug Compounding; Drug Delivery Systems; Drug Stability; Emulsifying Agents; Emulsions; Male; Particle Size; Peptidomimetics; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Thiazolidines; Triglycerides; Viscosity; Water | 2011 |
The detailed analysis of the changes of murine dendritic cells (DCs) induced by thymic peptide: pidotimod(PTD).
Topics: Adjuvants, Immunologic; Animals; B7-1 Antigen; B7-2 Antigen; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Immunohistochemistry; Interleukin-12; Mice; Microscopy, Atomic Force; Microscopy, Electron, Transmission; Pyrrolidonecarboxylic Acid; Thiazolidines; Tumor Necrosis Factor-alpha | 2012 |
Synergistic effect of methionine encephalin (MENK) combined with pidotimod(PTD) on the maturation of murine dendritic cells (DCs).
Topics: Animals; Antigens, CD; Cell Differentiation; Cell Proliferation; Cells, Cultured; Dendritic Cells; Endocytosis; Enkephalin, Methionine; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Histocompatibility Antigens Class II; Immunologic Factors; Interleukin-12; Mice; Mice, Inbred C57BL; Microscopy; Pyrrolidonecarboxylic Acid; T-Lymphocytes; Thiazolidines; Tumor Necrosis Factor-alpha | 2013 |
Modulation of airway epithelial cell functions by Pidotimod: NF-kB cytoplasmatic expression and its nuclear translocation are associated with an increased TLR-2 expression.
Topics: Biomarkers; Blotting, Western; Bronchi; Cell Line; Cell Nucleus; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Flow Cytometry; Gene Expression Regulation; Humans; Immunologic Factors; Intercellular Adhesion Molecule-1; Interleukin-8; MAP Kinase Signaling System; NF-kappa B; Phosphorylation; Pyrrolidonecarboxylic Acid; Thiazolidines; Toll-Like Receptor 2; Translocation, Genetic; Tumor Necrosis Factor-alpha; Up-Regulation | 2013 |
Preventive effect of pidotimod on reactivated toxoplasmosis in mice.
Topics: Animals; Cyclophosphamide; Cytokines; Female; Gene Expression Regulation; Immunologic Factors; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Parasitemia; Pyrrolidonecarboxylic Acid; Specific Pathogen-Free Organisms; Spleen; Thiazolidines; Toxoplasmosis, Animal | 2013 |
Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Protozoan; Antigens, Protozoan; Cytokines; Disease Models, Animal; Female; Humans; Immunoglobulin G; Injections, Intraperitoneal; Liver; Mice; Protozoan Proteins; Protozoan Vaccines; Pyrrolidonecarboxylic Acid; Species Specificity; Specific Pathogen-Free Organisms; Spleen; Thiazolidines; Toxoplasma; Toxoplasmosis; Ultraviolet Rays; Vaccination; Vaccines, Attenuated | 2013 |
Pidotimod: the past and the present.
Topics: Acute Disease; Adaptive Immunity; Adjuvants, Immunologic; Animals; Child; Child, Preschool; Cohort Studies; Disease Models, Animal; Female; Forecasting; Humans; Immunity, Innate; Incidence; Male; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; Risk Factors; Secondary Prevention; Thiazolidines; Treatment Outcome | 2013 |
Sublingual surprise: a new variant of oral lichen planus.
Topics: Adjuvants, Immunologic; Administration, Oral; Adolescent; Adult; Autoimmunity; Biopsy; Chronic Disease; Humans; Immunologic Factors; Lichen Planus, Oral; Male; Pyrrolidonecarboxylic Acid; Thiazolidines; Treatment Outcome | 2014 |
The regulatory peptide pidotimod facilitates M2 macrophage polarization and its function.
Topics: Animals; Biomarkers; Cell Polarity; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Peptides; Pyrrolidonecarboxylic Acid; Thiazolidines | 2014 |
[Pidotimod inhibits activation of latent Toxoplasma gondii infection induced by dexamethasone in mice].
Topics: Animals; Brain; Cytokines; Dexamethasone; DNA, Protozoan; Female; Mice; Mice, Inbred BALB C; Pyrrolidonecarboxylic Acid; T-Lymphocytes, Regulatory; Th1 Cells; Th2 Cells; Thiazolidines; Toxoplasma; Toxoplasmosis, Animal | 2013 |
[Effectiveness of pidotimod in combination with bacterial lysates in the treatment of the pfapa (periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis) syndrome].
Topics: Adjuvants, Immunologic; Cell Extracts; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Follow-Up Studies; Humans; Lymphadenitis; Male; Pharyngitis; Pyrrolidonecarboxylic Acid; Quality of Life; Stomatitis, Aphthous; Syndrome; Thiazolidines | 2015 |
Studies on Pidotimod Enantiomers With Chiralpak-IA: Crystal Structure, Thermodynamic Parameters and Molecular Docking.
Topics: Crystallography, X-Ray; Hydrogen Bonding; Molecular Docking Simulation; Molecular Structure; Pyrrolidonecarboxylic Acid; Stereoisomerism; Thermodynamics; Thiazolidines | 2015 |
A robust LC-MS/MS method for the determination of pidotimod in different biological matrixes and its application to in vivo and in vitro pharmacokinetic studies.
Topics: Animals; Caco-2 Cells; Chromatography, Liquid; Humans; Limit of Detection; Linear Models; Male; Pyrrolidonecarboxylic Acid; Rats, Sprague-Dawley; Reproducibility of Results; Tandem Mass Spectrometry; Thiazolidines | 2016 |
Effects of pidotimod soluble powder and immune enhancement of Newcastle disease vaccine in chickens.
Topics: Adjuvants, Immunologic; Animals; Avian Proteins; Chickens; Interferon-gamma; Interleukin-2; Newcastle Disease; Newcastle disease virus; Pyrrolidonecarboxylic Acid; Thiazolidines; Viral Vaccines | 2017 |
Pidotimod exacerbates allergic pulmonary infection in an OVA mouse model of asthma.
Topics: Animals; Arginase; Asthma; Bronchoalveolar Lavage Fluid; Cell Differentiation; Disease Models, Animal; Down-Regulation; Eosinophils; Female; Hypersensitivity; Immunoglobulin E; Intercellular Signaling Peptides and Proteins; Lung; Metaplasia; Mice, Inbred C57BL; Mucus; Ovalbumin; Pyrrolidonecarboxylic Acid; Respiratory Tract Infections; Th2 Cells; Thiazolidines | 2017 |
Pharmacokinetics of pidotimod in broiler chickens by UHPLC-MS/MS after oral and intravenous administration.
Topics: Administration, Oral; Animals; Biological Availability; Chickens; Chromatography, High Pressure Liquid; Immunologic Factors; Injections, Intravenous; Linear Models; Pyrrolidonecarboxylic Acid; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Thiazolidines | 2018 |
The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3).
Topics: Antibodies, Monoclonal; Cell Adhesion; Cell Movement; Cells, Cultured; Chemotaxis; Dipeptides; Humans; Monocytes; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Isoforms; Proto-Oncogene Proteins c-akt; Pyrrolidonecarboxylic Acid; Receptors, CXCR3; RNA Interference; RNA, Small Interfering; Signal Transduction; T-Lymphocytes; Thiazolidines | 2019 |
Effects of Pidotimod on recurrent respiratory infections in children with Down syndrome: a retrospective Italian study.
Topics: Adjuvants, Immunologic; Child; Child, Preschool; Down Syndrome; Female; Humans; Immunoglobulin Isotypes; Italy; Male; Pyrrolidonecarboxylic Acid; Recurrence; Respiratory Tract Infections; Retrospective Studies; Thiazolidines | 2020 |
Pidotimod enhanced the anti-growth effect of cisplatin on lung cancer in mice via promoting anti-tumor immune response.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Proliferation; Cisplatin; Dendritic Cells; Drug Synergism; Immunity; Mice; Pyrrolidonecarboxylic Acid; Thiazolidines | 2020 |
A Model for SARS-CoV-2 Infection with Treatment.
Topics: Adjuvants, Immunologic; Angiotensin-Converting Enzyme 2; Basic Reproduction Number; Betacoronavirus; Computer Simulation; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Host Microbial Interactions; Humans; Mathematical Concepts; Models, Biological; Mutation; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Pyrrolidonecarboxylic Acid; Receptors, Virus; SARS-CoV-2; Spike Glycoprotein, Coronavirus; T-Lymphocytes, Cytotoxic; Thiazolidines | 2020 |
Expert Opinion on Usage of Pidotimod in Adult Patients with Chronic Obstructive Pulmonary Disease: An Indian Perspective.
Topics: Adult; COVID-19; Expert Testimony; Humans; Pulmonary Disease, Chronic Obstructive; Pyrrolidonecarboxylic Acid; SARS-CoV-2; Thiazolidines | 2021 |
Prevention of recurrent respiratory infections : Inter-society Consensus.
Topics: Adenoidectomy; Adjuvants, Immunologic; Administration, Intranasal; Algorithms; Antibiotic Prophylaxis; Antioxidants; Child; Complementary Therapies; Humans; Hyaluronic Acid; Influenza Vaccines; Pneumococcal Vaccines; Prebiotics; Probiotics; Pyrrolidonecarboxylic Acid; Recurrence; Respiratory Tract Infections; Resveratrol; Thiazolidines; Tonsillectomy; Vitamins | 2021 |
Pidotimod increases inflammation in wounded zebrafish embryos.
Topics: Animals; Inflammation; Larva; Pyrrolidonecarboxylic Acid; Thiazolidines; Zebrafish | 2022 |